Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

Aeglea BioTherapeutics, Inc. (AGLE) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/30/2023 4 Alspaugh Jonathan (President and CFO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns: Granted 19,787,969 options to buy @ $0.3, valued at $5.9M
06/30/2023 4 Cox Russell J. (Director) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns: Granted 1,950,000 options to buy @ $0.3, valued at $585k
06/30/2023 4 Magovcevic-Liebisch Ivana (Director) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns: Granted 1,950,000 options to buy @ $0.3, valued at $585k
06/30/2023 4 Smith Hunter C (Director) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns: Granted 1,950,000 options to buy @ $0.3, valued at $585k
06/30/2023 4 Lawton Alison Frances (Director) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns: Granted 1,950,000 options to buy @ $0.3, valued at $585k
02/24/2023 4 Neuman Linda L (Chief Medical Officer) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns: Granted 550,000 options to buy @ $0.44, valued at $242k
02/24/2023 4 Kastenmayer James Paul (General Counsel) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns: Granted 500,000 options to buy @ $0.44, valued at $220k
02/24/2023 4 Hanley Jr. Michael Conick (Chief Business Officer) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns: Granted 500,000 options to buy @ $0.44, valued at $220k
02/24/2023 4 Alspaugh Jonathan (CFO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns: Granted 640,000 options to buy @ $0.44, valued at $281.6k
01/27/2023 4 Neuman Linda L (Chief Medical Officer) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns: Granted 25,000 options to buy @ $1.36, valued at $34k
12/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/25/2022 4 Kastenmayer James Paul (Interim CEO & General Counsel) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns: Granted 130,000 options to buy @ $0.68, valued at $88.4k
08/25/2022 4 Souza Marcio (Director) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns: Bought 90,000 shares @ $0.5608, valued at $50.5k
08/25/2022 4 Sloan Leslie (COO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns: Granted 130,000 options to buy @ $0.68, valued at $88.4k
08/25/2022 4 Hanley Jr. Michael Conick (Chief Business Officer) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns: Granted 130,000 options to buy @ $0.68, valued at $88.4k
08/25/2022 4 Alspaugh Jonathan (CFO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns: Granted 130,000 options to buy @ $0.68, valued at $88.4k
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/09/2022 4 Souza Marcio (Director) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns: Granted 43,000 options to buy @ $0.73, valued at $31.4k
06/09/2022 4 Smith Hunter C (Director) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns: Granted 43,000 options to buy @ $0.73, valued at $31.4k
06/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/18/2022 4 Quinn Anthony G. (President & CEO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns: Bought 80,079 shares @ $2.344, valued at $187.7k
03/15/2022 4 Quinn Anthony G. (President & CEO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns: Bought 34,777 shares @ $2.064, valued at $71.8k
Bought 67,472 shares @ $1.93, valued at $130.2k
Bought 42,417 shares @ $1.8611, valued at $78.9k
03/15/2022 4 Alspaugh Jonathan (CFO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns: Bought 75,000 shares @ $2.08, valued at $156k
02/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/22/2022 4 Weber Steven (VP, Controller&Princ Acctg Off) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns: Granted 30,000 options to buy @ $3.17, valued at $95.1k
02/22/2022 4 Sloan Leslie (COO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns: Granted 180,000 options to buy @ $3.17, valued at $570.6k
02/22/2022 4 Hanley Jr. Michael Conick (Chief Commercial Officer) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns: Granted 160,000 options to buy @ $3.17, valued at $507.2k
02/22/2022 4 Alspaugh Jonathan (CFO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns: Granted 170,000 options to buy @ $3.17, valued at $538.9k
12/13/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy